Search
Generic filters
Search in excerpt

An ETF for every investor.

CASH

Horizons High Interest Savings ETF

Price
$50.01
$0.01
0.02%
NAV
$49.9998
$-0.1671
-0.33%

Benchmark

Fixed Income

Fact Sheet
Learn more about CASH

QQCC

Horizons NASDAQ-100 Covered Call ETF

Price
$9.56
$-0.04
-0.42%
NAV
$9.8753
$0.2847
2.97%

Active

Covered Call

Fact Sheet
Learn more about QQCC

HRAA

Horizons ReSolve Adaptive Asset Allocation ETF

Price
$11.14
$-0.13
-1.15%
NAV
$11.2092
$-0.0103
-0.09%

Active

Corporate Class – Alternative

Fact Sheet
Learn more about HRAA
Explore All Products
Search
Generic filters
Search in excerpt
Back to All Products

PSYK

Horizons Psychedelic Stock Index ETF

The World’s First Psychedelics ETF

Within the last decade, there has been a significant re-evaluation of the potential therapeutic benefits of psychedelics, and a movement to research these substances and potentially use them for therapeutic use, particularly in the treatment of mental health issues. Horizons Psychedelic Stock Index ETF (PSYK) is the world’s first psychedelics-focused ETF providing investors a new way to get exposure to this emerging healthcare sector.

North American Psychedelics Index

Constituents are listed on North American exchanges and are publicly listed life sciences companies focused on psychedelic medicine, and other companies with business activities in the psychedelics industry. While securities may be listed on the TSX, NYSE or Nasdaq Global Market, many of these securities may trade on North American junior exchanges that include (but are not limited to) the:
• TSX Venture Exchange
• Canadian Securities Exchange
• NEO Exchange
• NASDAQ Stock Market
• NYSE American

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$16,441,474
As at  November 30, 2022
Consolidated Prior Day Volume ?
1,768
For  November 30, 2022
Average Daily Trading Volume Over a 12 Month Period ?
17,151
As at  November 30, 2022
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
1.00%
As at June 30, 2022
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
0.03023
Estimated Annualized Yield ?
0.42 %
12-Month Trailing Yield ?
-- %
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$8.1355
Price
$8.14
Premium Discount
$0.00
Premium Discount Percentage
0.06%
Outstanding Shares
2,020,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF -18.61 -26.44 -25.90 -54.43 -69.46 -- -- -- -56.64
North American Psychedelics Index -18.63 -25.80 -24.50 -53.90 -69.10 -- -- -- -58.73

**Fund performance since inception on January 26, 2021, as at October 31, 2022

Calendar Year Performance (%) *

Calendar year performance data is not currently available.

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023

Top 10 Holdings

As at November 25, 2022
Security Name Weight
GH RESEARCH PLC . 12.79%
SEELOS THERAPEUTICS INC . 12.35%
ATAI LIFE SCIENCES NV . 11.73%
COMPASS PATHWAYS PLC ADR 10.44%
Abbvie Inc 9.68%
Johnson & Johnson 8.98%
Numinus Wellness Inc 7.59%
CYBIN INC . 7.50%
REVIVE THERAPEUTICS LTD . 6.14%
MIND MEDICINE MINDMED INC 4.01%

Holdings are subject to change. Download full prior business day: Holdings

At a Glance

The World’s First Psychedelics ETF

Within the last decade, there has been a significant re-evaluation of the potential therapeutic benefits of psychedelics, and a movement to research these substances and potentially use them for therapeutic use, particularly in the treatment of mental health issues. Horizons Psychedelic Stock Index ETF (PSYK) is the world’s first psychedelics-focused ETF providing investors a new way to get exposure to this emerging healthcare sector.

North American Psychedelics Index

Constituents are listed on North American exchanges and are publicly listed life sciences companies focused on psychedelic medicine, and other companies with business activities in the psychedelics industry. While securities may be listed on the TSX, NYSE or Nasdaq Global Market, many of these securities may trade on North American junior exchanges that include (but are not limited to) the:
• TSX Venture Exchange
• Canadian Securities Exchange
• NEO Exchange
• NASDAQ Stock Market
• NYSE American

Product Facts

Investment Objective

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index, net of expenses.

Fund Details

Ticker
PSYK
Inception Date
January 26, 2021
Net Assets ?
$16,441,474
As at November 30, 2022
Consolidated Prior Day Volume ?
1,768
For November 30, 2022
Average Daily Trading Volume Over a 12 Month Period ?
17,151
As at November 30, 2022
Exchange
NEO Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
HPSYKTR
Management Fee
0.85%
(Plus applicable sales tax)
Management Expense Ratio ?
1.00%
 As at June 30, 2022
Currency
CAD
Currency Hedging
N/A
LEI ?
5493003DII1O2LYBVQ81
Most Recent Distributions Per Unit
0.03023
Estimated Annualized Yield ?
0.42%
12-Month Trailing Yield ?
--%
Distribution Frequency
Record Date
September 29, 2021
NAV / Unit
$8.1355
Price
$8.14
Premium Discount
$0.00
Premium Discount Percentage
0.06%
Outstanding Shares
2,020,954

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Performance & Distributions

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Psychedelic Stock Index ETF -18.61 -26.44 -25.90 -54.43 -69.46 -- -- -- -56.64
North American Psychedelics Index -18.63 -25.80 -24.50 -53.90 -69.10 -- -- -- -58.73

**Fund performance since inception on January 26, 2021, as at October 31, 2022

Calendar Year Performance (%)

Calendar year performance data is not currently available.

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2021 09/28/2021 09/29/2021 10/13/2021 0.03023
Holdings

Top 10 Holdings

As at November 25, 2022
Security Name Weight
GH RESEARCH PLC . 12.79%
SEELOS THERAPEUTICS INC . 12.35%
ATAI LIFE SCIENCES NV . 11.73%
COMPASS PATHWAYS PLC ADR 10.44%
Abbvie Inc 9.68%
Johnson & Johnson 8.98%
Numinus Wellness Inc 7.59%
CYBIN INC . 7.50%
REVIVE THERAPEUTICS LTD . 6.14%
MIND MEDICINE MINDMED INC 4.01%

Holdings are subject to change. Download full prior business day: Holdings

Related Posts

At Horizons ETFs, we believe in education as empowerment. We endeavor to equip Canadian investors with the knowledge and tools they need to navigate the investing world. From the ETF basics to more complex topics like how our suite of inverse and leveraged funds work, our comprehensive learning library aims to be accessible for all investors, from beginners to experienced traders!